Thirdly, further investigation is required to clarify the specific molecular mechanisms involved in FBXO44‐mediated ubiquitination, as well as to investigate the therapeutic potential of FBXO44 inhibitors in CRC. Here, FBXO44 is linked to colorectal carcinoma.